A Narrative Review of Revascularization in Chronic Coronary Syndrome/Disease: Concepts and Misconceptions
Abstract
:1. Introduction
2. Why Revascularize CCS Patients?
2.1. Revascularization—The Prognosis Rationale
2.1.1. Patients without Left Main Disease and Preserved Left Ventricular Ejection Fraction
2.1.2. Patients with Reduced Left Ventricular Ejection Fraction
2.1.3. Patients with Vulnerable Plaques
3. Revascularizing Patients for Symptomatic Relief
4. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Timmis, A.; Vardas, P.; Townsend, N.; Torbica, A.; Katus, H.; De Smedt, D.; Gale, C.P.; Maggioni, A.P.; Petersen, S.E.; Huculeci, R.; et al. European Society of Cardiology: Cardiovascular disease statistics 2021. Eur. Heart J. 2022, 43, 716–799. [Google Scholar] [CrossRef] [PubMed]
- GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392, 1736–1788. [Google Scholar] [CrossRef] [PubMed]
- Knuuti, J.; Wijns, W.; Saraste, A.; Capodanno, D.; Barbato, E.; Funck-Brentano, C.; Prescott, E.; Storey, R.F.; Deaton, C.; Cuisset, T.; et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 2020, 41, 407–477. [Google Scholar] [CrossRef] [PubMed]
- Neumann, F.J.; Sousa-Uva, M.; Ahlsson, A.; Alfonso, F.; Banning, A.P.; Benedetto, U.; Byrne, R.A.; Collet, J.P.; Falk, V.; Head, S.J.; et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019, 40, 87–165. [Google Scholar] [CrossRef] [PubMed]
- Maron, D.J.; Hochman, J.S.; Reynolds, H.R.; Bangalore, S.; O’Brien, S.M.; Boden, W.E.; Chaitman, B.R.; Senior, R.; López-Sendón, J.; Alexander, K.P.; et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N. Engl. J. Med. 2020, 382, 1395–1407. [Google Scholar] [CrossRef] [PubMed]
- Virani, S.S.; Newby, L.K.; Arnold, S.V.; Bittner, V.; Brewer, L.C.; Demeter, S.H.; Dixon, D.L.; Fearon, W.F.; Hess, B.; Johnson, H.M.; et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 2023, 148, E9–E119. [Google Scholar] [CrossRef]
- Lawton, J.S.; Tamis-Holland, J.E.; Bangalore, S.; Bates, E.R.; Beckie, T.M.; Bischoff, J.M.; Bittl, J.A.; Cohen, M.G.; DiMaio, J.M.; Don, C.W.; et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022, 145, E18–E114. [Google Scholar] [CrossRef] [PubMed]
- Mesnier, J.; Ducrocq, G.; Danchin, N.; Ferrari, R.; Ford, I.; Tardif, J.-C.; Tendera, M.; Fox, K.M.; Steg, P.G. International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study. Circulation 2021, 144, 512–523. [Google Scholar] [CrossRef] [PubMed]
- Spertus, J.A.; Salisbury, A.C.; Jones, P.G.; Conaway, D.G.; Thompson, R.C. Predictors of quality-of-life benefit after percutaneous coronary intervention. Circulation 2004, 110, 3789–3794. [Google Scholar] [CrossRef]
- Yusuf, S.; Zucker, D.; Passamani, E.; Peduzzi, P.; Takaro, T.; Fisher, L.; Kennedy, J.; Davis, K.; Killip, T.; Norris, R.; et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994, 344, 563–570. [Google Scholar] [CrossRef]
- Gaba, P.; Gersh, B.J.; Muller, J.; Narula, J.; Stone, G.W. Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: Implications for patient care and future research. Nat. Rev. Cardiol. 2023, 20, 181–196. [Google Scholar] [CrossRef] [PubMed]
- Kedhi, E.; Berta, B.; Roleder, T.; Hermanides, R.S.; Fabris, E.; Ijsselmuiden, A.J.J.; Kauer, F.; Alfonso, F.; von Birgelen, C.; Escaned, J.; et al. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: The COMBINE OCT–FFR trial. Eur. Heart J. 2021, 42, 4671–4679. [Google Scholar] [CrossRef] [PubMed]
- Mol, J.-Q.; Volleberg, R.H.J.A.; Belkacemi, A.; Hermanides, R.S.; Meuwissen, M.; Protopopov, A.V.; Laanmets, P.; Krestyaninov, O.V.; Dennert, R.; Oemrawsingh, R.M.; et al. Fractional Flow Reserve–Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction. JAMA Cardiol. 2023, 8, 1013. [Google Scholar] [CrossRef] [PubMed]
- Park, S.-J.; Ahn, J.-M.; Kang, D.-Y.; Yun, S.-C.; Ahn, Y.-K.; Kim, W.-J.; Jeong, J.-O.; Chae, I.-H.; Kao, H.-L.; Hahn, J.-Y.; et al. Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): A multicentre, open-label, randomised controlled trial. Lancet 2024, 403, 1753–1765. [Google Scholar] [CrossRef]
- Boden, W.E.; O’Rourke, R.A.; Teo, K.K.; Hartigan, P.M.; Maron, D.J.; Kostuk, W.J.; Knudtson, M.; Dada, M.; Casperson, P.; Harris, C.L.; et al. Optimal Medical Therapy with or without PCI for Stable Coronary Disease. N. Engl. J. Med. 2007, 356, 1503–1516. [Google Scholar] [CrossRef]
- Gensini, G.G.; Kelly, A.E.; Da Costa, B.C.B.; Huntington, P.P. Quantitative angiography: The measurement of coronary vasomobility in the intact animal and man. Chest 1971, 60, 522–530. [Google Scholar] [CrossRef]
- Fischer, J.J.; Samady, H.; McPherson, J.A.; Sarembock, I.J.; Powers, E.R.; Gimple, L.W.; Ragosta, M. Comparison Between Visual Assessment and Quantitative Angiography Versus Fractional Flow Reserve for Native Coronary Narrowings of Moderate Severity. Am. J. Cardiol. 2002, 90, 210–215. [Google Scholar] [CrossRef]
- Beauman, G.; Vogel, R. Accuracy of individual and panel visual interpretations of coronary arteriograms: Implications for clinical decisions. J. Am. Coll. Cardiol. 1990, 16, 108–113. [Google Scholar] [CrossRef]
- Zhang, H.; Mu, L.; Hu, S.; Nallamothu, B.K.; Lansky, A.J.; Xu, B.; Bouras, G.; Cohen, D.J.; Spertus, J.A.; Masoudi, F.A.; et al. Comparison of Physician Visual Assessment With Quantitative Coronary Angiography in Assessment of Stenosis Severity in China. JAMA Intern. Med. 2018, 178, 239. [Google Scholar] [CrossRef]
- Menezes, M.N.; Silva, B.; Silva, J.L.; Rodrigues, T.; Marques, J.S.; Guerreiro, C.; Guedes, J.P.; Oliveira-Santos, M.; Oliveira, A.L.; Pinto, F.J. Segmentation of X-ray coronary angiography with an artificial intelligence deep learning model: Impact in operator visual assessment of coronary stenosis severity. Catheter. Cardiovasc. Interv. 2023, 102, 631–640. [Google Scholar] [CrossRef]
- Shaw, L.J.; Weintraub, W.S.; Maron, D.J.; Hartigan, P.M.; Hachamovitch, R.; Min, J.K.; Dada, M.; Mancini, G.J.; Hayes, S.W.; O’Rourke, R.A.; et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am. Heart J. 2012, 164, 243–250. [Google Scholar] [CrossRef]
- Padala, S.K.; Sidhu, M.S.; Hartigan, P.M.; Maron, D.J.; Teo, K.K.; Spertus, J.A.; Mancini, G.J.; Sedlis, S.P.; Chaitman, B.R.; Heller, G.V.; et al. Effect of Baseline Exercise Capacity on Outcomes in Patients with Stable Coronary Heart Disease (A Post Hoc Analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial). Am. J. Cardiol. 2015, 116, 1509–1515. [Google Scholar] [CrossRef] [PubMed]
- Sedlis, S.P.; Hartigan, P.M.; Teo, K.K.; Maron, D.J.; Spertus, J.A.; Mancini, G.J.; Kostuk, W.; Chaitman, B.R.; Berman, D.; Lorin, J.D.; et al. Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. N. Engl. J. Med. 2015, 373, 1937–1946. [Google Scholar] [CrossRef]
- Changal, K.H.; Mir, T.; Khan, S.; Nazir, S.; Elzanatey, A.; Meenakshisundaram, C.; Mubbasher, S.; Sheikh, M.A. Drug-Eluting Stents Versus Bare-Metal Stents in Large Coronary Artery Revascularization: Systematic Review and Meta-Analysis. Cardiovasc. Revascularization Med. 2021, 23, 42–49. [Google Scholar] [CrossRef] [PubMed]
- Piccolo, R.; Bonaa, K.H.; Efthimiou, O.; Varenne, O.; Urban, P.; Kaiser, C.; Räber, L.; de Belder, A.; Remkes, W.; Hof, A.W.J.V.; et al. Drug–Eluting or Bare–Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization. J. Am. Heart Assoc. 2021, 10, e018828. [Google Scholar] [CrossRef] [PubMed]
- Remkes, W.S.; Badings, E.A.; Hermanides, R.S.; Rasoul, S.; Dambrink, J.-H.E.; Koopmans, P.C.; The, S.H.; Ottervanger, J.P.; Gosselink, A.T.M.; Hoorntje, J.C.; et al. Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction. Open Heart 2016, 3, e000455. [Google Scholar] [CrossRef]
- Frye, R.L.; August, P.; Brooks, M.M.; Hardison, R.M.; Kelsey, S.F.; MacGregor, J.M.; Orchard, T.J.; Chaitman, B.R.; Genuth, S.M.; Goldberg, S.H.; et al. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. N. Engl. J. Med. 2009, 360, 2503–2515. [Google Scholar] [CrossRef]
- Farkouh, M.E.; Domanski, M.; Sleeper, L.A.; Siami, F.S.; Dangas, G.; Mack, M.; Yang, M.; Cohen, D.J.; Rosenberg, Y.; Solomon, S.D.; et al. Strategies for Multivessel Revascularization in Patients with Diabetes. N. Engl. J. Med. 2012, 367, 2375–2384. [Google Scholar] [CrossRef]
- Bech, G.J.; Bruyne, B.D.; Pijls, N.H.; de Muinck, E.D.; Hoorntje, J.C.; Escaned, J.; Stella, P.R.; Boersma, E.; Bartunek, J.; Koolen, J.J.; et al. Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis A Randomized Trial. Circulation 2001, 103, 2928–2934. [Google Scholar] [CrossRef] [PubMed]
- Tonino, P.A.L.; De Bruyne, B.; Pijls, N.H.J.; Siebert, U.; Ikeno, F.; van’t Veer, M.; Klauss, V.; Manoharan, G.; Engstrøm, T.; Oldroyd, K.G.; et al. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention. N. Engl. J. Med. 2009, 360, 213–224. [Google Scholar] [CrossRef]
- Xu, B.; Tu, S.; Song, L.; Jin, Z.; Yu, B.; Fu, G.; Zhou, Y.; Wang, J.; Chen, Y.; Pu, J.; et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): A multicentre, randomised, sham-controlled trial. Lancet 2021, 398, 2149–2159. [Google Scholar] [CrossRef] [PubMed]
- De Bruyne, B.; Pijls, N.H.; Kalesan, B.; Barbato, E.; Tonino, P.A.; Piroth, Z.; Jagic, N.; Mobius-Winckler, S.; Rioufol, G.; Witt, N.; et al. Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease. N. Engl. J. Med. 2012, 367, 991–1001. [Google Scholar] [CrossRef] [PubMed]
- Xaplanteris, P.; Fournier, S.; Pijls, N.H.; Fearon, W.F.; Barbato, E.; Tonino, P.A.; Engstrøm, T.; Kääb, S.; Dambrink, J.-H.; Rioufol, G.; et al. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. N. Engl. J. Med. 2018, 379, 250–259. [Google Scholar] [CrossRef] [PubMed]
- Stone, G.W.; Christiansen, E.H.; Ali, Z.A.; Andreasen, L.N.; Maehara, A.; Ahmad, Y.; Landmesser, U.; Holm, N.R. Intravascular imaging-guided coronary drug-eluting stent implantation: An updated network meta-analysis. Lancet 2024, 403, 824–837. [Google Scholar] [CrossRef] [PubMed]
- Saylik, F.; Cinar, T.; Selcuk, M.; Cicek, V.; Hayiroglu, M.I.; Orhan, A.L. Comparison of outcomes between single long stent and overlapping stents: A meta-analysis of the literature. Herz 2023, 48, 376–383. [Google Scholar] [CrossRef] [PubMed]
- Chaitman, B.R.; Alexander, K.P.; Cyr, D.D.; Berger, J.S.; Reynolds, H.R.; Bangalore, S.; Boden, W.E.; Lopes, R.D.; Demkow, M.; Perna, G.P.; et al. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. Circulation 2021, 143, 790–804. [Google Scholar] [CrossRef] [PubMed]
- Bolognese, L.; Reccia, M.R.; Sabini, A. Long-term follow-up after invasive or conservative management of stable coronary disease: The ISCHEMIA-EXTEND study. Eur. Heart J. Suppl. 2023, 25, B34–B36. [Google Scholar] [CrossRef] [PubMed]
- Figtree, G.A.; Vernon, S.T.; Hadziosmanovic, N.; Sundström, J.; Alfredsson, J.; Nicholls, S.J.; Chow, C.K.; Psaltis, P.; Røsjø, H.; Leósdóttir, M.; et al. Mortality and Cardiovascular Outcomes in Patients Presenting With Non–ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry. J. Am. Heart Assoc. 2022, 11, e024818. [Google Scholar] [CrossRef] [PubMed]
- Bangalore, S.; Maron, D.J.; O’brien, S.M.; Fleg, J.L.; Kretov, E.I.; Briguori, C.; Kaul, U.; Reynolds, H.R.; Mazurek, T.; Sidhu, M.S.; et al. Management of Coronary Disease in Patients with Advanced Kidney Disease. N. Engl. J. Med. 2020, 382, 1608–1618. [Google Scholar] [CrossRef]
- Collet, C.; Sonck, J.; Vandeloo, B.; Mizukami, T.; Roosens, B.; Lochy, S.; Argacha, J.-F.; Schoors, D.; Colaiori, I.; Di Gioia, G.; et al. Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis. J. Am. Coll. Cardiol. 2019, 74, 1772–1784. [Google Scholar] [CrossRef]
- Ahn, J.-M.; Kang, D.-Y.; Lee, P.H.; Ahn, Y.-K.; Kim, W.-J.; Nam, C.-W.; Jeong, J.-O.; Chae, I.-H.; Shiomi, H.; Kao, P.H.L.; et al. Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial. Am. Heart J. 2023, 264, 83–96. [Google Scholar] [CrossRef] [PubMed]
- Velazquez, E.J.; Lee, K.L.; Deja, M.A.; Jain, A.; Sopko, G.; Marchenko, A.; Ali, I.S.; Pohost, G.; Gradinac, S.; Abraham, W.T.; et al. Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. N. Engl. J. Med. 2011, 364, 1607–1616. [Google Scholar] [CrossRef] [PubMed]
- Velazquez, E.J.; Lee, K.L.; Jones, R.H.; Al-Khalidi, H.R.; Hill, J.A.; Panza, J.A.; Michler, R.E.; Bonow, R.O.; Doenst, T.; Petrie, M.C.; et al. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N. Engl. J. Med. 2016, 374, 1511–1520. [Google Scholar] [CrossRef] [PubMed]
- Perera, D.; Clayton, T.; O’kane, P.D.; Greenwood, J.P.; Weerackody, R.; Ryan, M.; Morgan, H.P.; Dodd, M.; Evans, R.; Canter, R.; et al. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction. N. Engl. J. Med. 2022, 387, 1351–1360. [Google Scholar] [CrossRef] [PubMed]
- Perera, D.; Clayton, T.; Petrie, M.C.; Greenwood, J.P.; O’kane, P.D.; Evans, R.; Sculpher, M.; Mcdonagh, T.; Gershlick, A.; de Belder, M.; et al. Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial. JACC Heart Fail. 2018, 6, 517–526. [Google Scholar] [CrossRef] [PubMed]
- Allman, K.C.; Shaw, L.J.; Hachamovitch, R.; Udelson, J.E. Coronary Revascularization Myocardial Viability Testing and Impact of Revascularization on Prognosis in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: A Meta-Analysis. J. Am. Coll. Cardiol. 2002, 39, 1151–1158. [Google Scholar] [CrossRef] [PubMed]
- Perera, D.; Ryan, M.; Morgan, H.P.; Greenwood, J.P.; Petrie, M.C.; Dodd, M.; Weerackody, R.; O’kane, P.D.; Masci, P.G.; Nazir, M.S.; et al. Viability and Outcomes with Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial. JAMA Cardiol. 2023, 8, 1154–1161. [Google Scholar] [CrossRef] [PubMed]
- Serruys, P.W.; Morice, M.-C.; Kappetein, A.P.; Colombo, A.; Holmes, D.R.; Mack, M.J.; Ståhle, E.; Feldman, T.E.; Van Den Brand, M.; Bass, E.J.; et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N. Engl. J. Med. 2009, 360, 961–972. [Google Scholar] [CrossRef] [PubMed]
- Omar, W.A.; Kumbhani, D.J. The Current Literature on Bioabsorbable Stents: A Review. Curr. Atheroscler. Rep. 2019, 21, 54. [Google Scholar] [CrossRef]
- Wald, D.S.; Morris, J.K.; Wald, N.J.; Chase, A.J.; Edwards, R.J.; Hughes, L.O.; Berry, C.; Oldroyd, K.G. Randomized Trial of Preventive Angioplasty in Myocardial Infarction. N. Engl. J. Med. 2013, 369, 1115–1123. [Google Scholar] [CrossRef]
- Gershlick, A.H.; Khan, J.N.; Kelly, D.J.; Greenwood, J.P.; Sasikaran, T.; Curzen, N.; Blackman, D.J.; Dalby, M.; Fairbrother, K.L.; Banya, W.; et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for stemi and multivessel disease: The CvLPRIT trial. J. Am. Coll. Cardiol. 2015, 65, 963–972. [Google Scholar] [CrossRef] [PubMed]
- Engstrøm, T.; Kelbæk, H.; Helqvist, S.; Høfsten, D.E.; Kløvgaard, L.; Holmvang, L.; Jørgensen, E.; Pedersen, F.; Saunamäki, K.; Clemmensen, P.; et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): An open-label, randomised controlled trial. Lancet 2015, 386, 665–671. [Google Scholar] [CrossRef] [PubMed]
- Smits, P.C.; Abdel-Wahab, M.; Neumann, F.-J.; Klerk, B.M.B.-D.; Lunde, K.; Schotborgh, C.E.; Piroth, Z.; Horak, D.; Wlodarczak, A.; Ong, P.J.; et al. Fractional Flow Reserve–Guided Multivessel Angioplasty in Myocardial Infarction. N. Engl. J. Med. 2017, 376, 1234–1244. [Google Scholar] [CrossRef] [PubMed]
- Mehta, S.R.; Wood, D.A.; Storey, R.F.; Mehran, R.; Bainey, K.R.; Nguyen, H.; Meeks, B.; Di Pasquale, G.; López-Sendón, J.; Faxon, D.P.; et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N. Engl. J. Med. 2019, 381, 1411–1421. [Google Scholar] [CrossRef] [PubMed]
- Bainey, K.R.; Engstrm, T.; Smits, P.C.; Gershlick, A.H.; James, S.K.; Storey, R.F.; Wood, D.A.; Mehran, R.; Cairns, J.A.; Mehta, S.R. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction. JAMA Cardiol. 2020, 5, 881. [Google Scholar] [CrossRef] [PubMed]
- Kuck, K.-H.; Albenque, J.-P.; Chun, K.J.; Fürnkranz, A.; Busch, M.; Elvan, A.; Schlüter, M.; Braegelmann, K.M.; Kueffer, F.J.; Hemingway, L.; et al. Repeat Ablation for Atrial Fibrillation Recurrence Post Cryoballoon or Radiofrequency Ablation in the FIRE and ICE Trial. Circ. Arrhythm. Electrophysiol. 2019, 12, e007247. [Google Scholar] [CrossRef]
- Böhm, F.; Mogensen, B.; Engstrøm, T.; Stankovic, G.; Srdanovic, I.; Lønborg, J.; Zwackman, S.; Hamid, M.; Kellerth, T.; Lauermann, J.; et al. FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction. N. Engl. J. Med. 2024, 390, 1481–1492. [Google Scholar] [CrossRef] [PubMed]
- Puymirat, E.; Cayla, G.; Simon, T.; Steg, P.G.; Montalescot, G.; Durand-Zaleski, I.; le Bras, A.; Gallet, R.; Khalife, K.; Morelle, J.-F.; et al. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. N. Engl. J. Med. 2021, 385, 297–308. [Google Scholar] [CrossRef]
- Dambalkar, A.; Singh, A. Objective randomized blinded investigation with optimal medical therapy of angioplasty in stable angina. J. Pract. Cardiovasc. Sci. 2017, 3, 160. [Google Scholar] [CrossRef]
- Al-Lamee, R.K.; Shun-Shin, M.J.; Howard, J.P.; Nowbar, A.N.; Rajkumar, C.; Thompson, D.; Sen, S.; Nijjer, S.; Petraco, R.; Davies, J.; et al. Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease. Circulation 2019, 140, 1971–1980. [Google Scholar] [CrossRef]
- Ganesananthan, S.; Rajkumar, C.A.; Foley, M.; Thompson, D.; Nowbar, A.N.; Seligman, H.; Petraco, R.; Sen, S.; Nijjer, S.; Thom, S.A.; et al. Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: A substudy of the ORBITA trial. Eur. Heart J. 2022, 43, 3132–3145. [Google Scholar] [CrossRef] [PubMed]
- Rajkumar, C.A.; Foley, M.J.; Ahmed-Jushuf, F.; Nowbar, A.N.; Simader, F.A.; Davies, J.R.; O’kane, P.D.; Haworth, P.; Routledge, H.; Kotecha, T.; et al. A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina. N. Engl. J. Med. 2023, 389, 2319–2330. [Google Scholar] [CrossRef] [PubMed]
- Grüntzig, A.R.; Senning, Å.; Siegenthaler, W.E. Nonoperative Dilatation of Coronary-Artery Stenosis. N. Engl. J. Med. 1979, 301, 61–68. [Google Scholar] [CrossRef] [PubMed]
- Sones, F.M.; Shirey, E.K. Cine coronary arteriography. Mod. Concepts. Cardiovasc. Dis. 1962, 31, 735–738. [Google Scholar] [CrossRef] [PubMed]
- Berry, D. History of cardiology: Eduardo de Araýjo Coelho, MD, PhD. Circulation 2007, 116, f77-8. [Google Scholar]
- Green, G.E.; Stertzer, S.H.; Reppert, E.H. Coronary arterial bypass grafts. Ann. Thorac. Surg 1968, 5, 443–450. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nogueira-Garcia, B.; Vilela, M.; Oliveira, C.; Caldeira, D.; Martins, A.M.; Nobre Menezes, M. A Narrative Review of Revascularization in Chronic Coronary Syndrome/Disease: Concepts and Misconceptions. J. Pers. Med. 2024, 14, 506. https://doi.org/10.3390/jpm14050506
Nogueira-Garcia B, Vilela M, Oliveira C, Caldeira D, Martins AM, Nobre Menezes M. A Narrative Review of Revascularization in Chronic Coronary Syndrome/Disease: Concepts and Misconceptions. Journal of Personalized Medicine. 2024; 14(5):506. https://doi.org/10.3390/jpm14050506
Chicago/Turabian StyleNogueira-Garcia, Beatriz, Marta Vilela, Catarina Oliveira, Daniel Caldeira, Ana Margarida Martins, and Miguel Nobre Menezes. 2024. "A Narrative Review of Revascularization in Chronic Coronary Syndrome/Disease: Concepts and Misconceptions" Journal of Personalized Medicine 14, no. 5: 506. https://doi.org/10.3390/jpm14050506